September 2020 Kontos Kommentary
The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global. KAR Global is a leading provider of wholesale used vehicle auctions and ancillary remarketing services.1
September 2020 Kontos Kommentary
The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global. KAR Global is a leading provider of wholesale used vehicle auctions and ancillary remarketing services.1
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.
Enlyte report shows migraine medications gaining popularity in workers' comp while opioid prescriptions continue downward trend in 2024.
New Enlyte report reveals shifting trends: migraine medications up 8.7%, while opioid prescriptions decline 7.8% in workers' comp claims for 2024.
Enlyte's 2025 Drug Trends Report shows rise in migraine medications while opioid use declines in workers' compensation claims.